Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine [2]

Journal of Clinical Psychopharmacology

Volumn 19, Issue 4, 1999, Pages 378-380

  Weiss, E L ^a   Longhurst, J G ^a   Bowers, M B ^a   Mazure, C M ^a  

^a Yale University School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; OLANZAPINE; PLACEBO;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERSALIVATION; LETTER; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOIDISM; SCHIZOPHRENIA; SEDATION;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; PIRENZEPINE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 0032767150     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199908000-00017     Document Type: Letter

References (10)